首页 > 最新文献

Journal of Mental Health Policy and Economics最新文献

英文 中文
Organizing mental health services: an evidence-based approach 组织心理健康服务:循证方法
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2000-11-23 DOI: 10.1002/1099-176X(200006)3:2<69::AID-MHP76>3.0.CO;2-1
Howard H. Goldman, Sten Thelander, Claes-Goran Westrin
<div> <section> <h3> <b>Background and Aims.</b></h3> <p> Health policy makers and program developers seek evidence-based guidance on how to organize and finance mental health services. The Swedish Council on Technology Assessment in Health Care (SBU) commissioned a conceptual framework for thinking about health care services as a medical technology. The following framework was developed, citing empirical research from mental health services research as the case example.</p> </section> <section> <h3> <b>Framework.</b></h3> <p> Historically, mental health services have focused on the organization and locus of care. Health care settings have been conceptualized as medical technologies, treatments in themselves. For example, the field speaks of an era of ‘asylum treatment’ and ‘community care’. Hospitals and community mental health centers are viewed as treatments with indications and ‘dosages’, such as length of stay criteria. Assessment of mental health services often has focused on organizations and on administrative science.</p> <p>There are two principal perspectives for assessing the contribution of the organization of services on health. One perspective is derived from clinical services research, in which the focus is on the impact of organized treatments (and their most common settings) on health status of individuals. The other perspective is based in service systems research, in which the focus is on the impact of organizational strategies on intermediate service patterns, such as continuity of care or integration, as well as health status.</p> </section> <section> <h3> <b>Methods.</b></h3> <p> Examples of empirical investigations from clinical services research and service systems research are presented to demonstrate potential sources of evidence to support specific decisions for organizing mental health services.</p> </section> <section> <h3> <b>Results.</b></h3> <p> Evidence on organizing mental health services may be found in both types of services research. In clinical services research studies, service settings are viewed as treatments (e.g. ‘partial hospitalization’), some treatments are always embedded in a service matrix (e.g. assertive community treatment), and, where some treatments are organizationally combined (e.g. ‘integrated treatment’ for co-occurring mental disorder and substance abuse), sometimes into a continuum of care. In service system research, integration of services and of the service system are the main focus of investigation. Studies focus on horizontal and vertical integration, primary care or specialty care and local mental health authorities—each of which ma
背景和目的。卫生政策制定者和项目开发人员寻求关于如何组织和资助心理健康服务的循证指导。瑞典卫生保健技术评估委员会(SBU)委托制定了一个概念框架,将卫生保健服务视为一种医疗技术。以下框架是以心理健康服务研究的实证研究为例制定的。框架从历史上看,心理健康服务一直侧重于护理的组织和场所。医疗保健环境已经被概念化为医疗技术,治疗本身。例如,该领域谈到了一个“庇护治疗”和“社区护理”的时代。医院和社区心理健康中心被视为具有适应症和“剂量”的治疗方法,如住院时间标准。对心理健康服务的评估往往侧重于组织和行政科学。评估服务组织对健康的贡献有两个主要观点。一种观点来自临床服务研究,其中重点是有组织的治疗(及其最常见的环境)对个人健康状况的影响。另一个视角是基于服务系统研究,重点是组织战略对中间服务模式的影响,如护理或整合的连续性以及健康状况。方法。提供了临床服务研究和服务系统研究的实证调查示例,以证明支持组织心理健康服务的具体决策的潜在证据来源。后果关于组织心理健康服务的证据可以在这两种类型的服务研究中找到。在临床服务研究中,服务环境被视为治疗(例如“部分住院”),一些治疗总是嵌入服务矩阵中(例如自信的社区治疗),并且,在一些治疗是组织结合的情况下(例如,对同时发生的精神障碍和药物滥用的“综合治疗”),有时会纳入连续的护理。在服务系统研究中,服务与服务系统的集成是研究的重点。研究的重点是横向和纵向一体化、初级保健或专科护理以及地方心理健康主管部门——每一项都可以被概念化为一项医疗保健技术,并有大量证据评估其有效性。含义。评估作为医疗保健技术的服务组织的概念框架将注意力集中在指导计划设计和政策制定的证据上。心理健康服务研究有望为此类决策提供指导。版权所有©2000 John Wiley&;有限公司。
{"title":"Organizing mental health services: an evidence-based approach","authors":"Howard H. Goldman,&nbsp;Sten Thelander,&nbsp;Claes-Goran Westrin","doi":"10.1002/1099-176X(200006)3:2<69::AID-MHP76>3.0.CO;2-1","DOIUrl":"https://doi.org/10.1002/1099-176X(200006)3:2<69::AID-MHP76>3.0.CO;2-1","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; &lt;b&gt;Background and Aims.&lt;/b&gt;&lt;/h3&gt;\u0000 \u0000 &lt;p&gt; Health policy makers and program developers seek evidence-based guidance on how to organize and finance mental health services. The Swedish Council on Technology Assessment in Health Care (SBU) commissioned a conceptual framework for thinking about health care services as a medical technology. The following framework was developed, citing empirical research from mental health services research as the case example.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; &lt;b&gt;Framework.&lt;/b&gt;&lt;/h3&gt;\u0000 \u0000 &lt;p&gt; Historically, mental health services have focused on the organization and locus of care. Health care settings have been conceptualized as medical technologies, treatments in themselves. For example, the field speaks of an era of ‘asylum treatment’ and ‘community care’. Hospitals and community mental health centers are viewed as treatments with indications and ‘dosages’, such as length of stay criteria. Assessment of mental health services often has focused on organizations and on administrative science.&lt;/p&gt;\u0000 \u0000 &lt;p&gt;There are two principal perspectives for assessing the contribution of the organization of services on health. One perspective is derived from clinical services research, in which the focus is on the impact of organized treatments (and their most common settings) on health status of individuals. The other perspective is based in service systems research, in which the focus is on the impact of organizational strategies on intermediate service patterns, such as continuity of care or integration, as well as health status.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; &lt;b&gt;Methods.&lt;/b&gt;&lt;/h3&gt;\u0000 \u0000 &lt;p&gt; Examples of empirical investigations from clinical services research and service systems research are presented to demonstrate potential sources of evidence to support specific decisions for organizing mental health services.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; &lt;b&gt;Results.&lt;/b&gt;&lt;/h3&gt;\u0000 \u0000 &lt;p&gt; Evidence on organizing mental health services may be found in both types of services research. In clinical services research studies, service settings are viewed as treatments (e.g. ‘partial hospitalization’), some treatments are always embedded in a service matrix (e.g. assertive community treatment), and, where some treatments are organizationally combined (e.g. ‘integrated treatment’ for co-occurring mental disorder and substance abuse), sometimes into a continuum of care. In service system research, integration of services and of the service system are the main focus of investigation. Studies focus on horizontal and vertical integration, primary care or specialty care and local mental health authorities—each of which ma","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"3 2","pages":"69-75"},"PeriodicalIF":1.6,"publicationDate":"2000-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/1099-176X(200006)3:2<69::AID-MHP76>3.0.CO;2-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72162501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 34
Using randomized controlled trials to evaluate socially complex services: problems, challenges and recommendations 使用随机对照试验评估社会复杂服务:问题、挑战和建议
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2000-11-23 DOI: 10.1002/1099-176X(200006)3:2<97::AID-MHP77>3.0.CO;2-S
Nancy Wolff
<div> <section> <h3> <b>Background:</b></h3> <p> Following the lead of evidence-based medicine, practice based on effectiveness research has become the new gold standard of contemporary public policy. Studies of this sort are increasingly demanded to evaluate services provided by mental health, social services and criminal justice systems.</p> </section> <section> <h3> <b>Aims:</b></h3> <p> The paper questions whether the simple randomized controlled trial (RCT) paradigm as applied in clinical trials can be used ‘off the rack’ to evaluate <i>socially complex service (SCS) interventions</i>. These are services that are characterized by complex, diverse and non-standardized staffing arrangements; ambiguous protocols; hard-to-define study samples and unevenly motivated subjects and dependence on broader social environments. The difficulty of ensuring precise protocols, equivalent groups (tied to a meaningful target population) and neutral and equivalent trial environments under real world conditions are explored, as are the implications of not achieving standardization and equivalence.</p> </section> <section> <h3> <b>Methods:</b></h3> <p> Limitations of effectiveness research as a research tool and information source are examined by comparing the assumptions underpinning the simple RCT to the characteristics of SCS interventions, as illustrated by programs targeted to mentally disordered offenders in Britain.</p> </section> <section> <h3> <b>Results:</b></h3> <p> SCSs violate the assumptions underpinning the simple RCT model in ways that draw into sharp question the validity, reliability and generalizability of inferences of SCS trials.</p> </section> <section> <h3> <b>Discussion:</b></h3> <p> The RCT is not a panacea. Effectiveness research of SCS interventions that is based on the RCT model is unlikely to yield valid, reliable and generalizable inferences without becoming more complex in design and more sensitive to issues of selection bias, unmeasured variables and endogeneity. Ten recommendations are offered for stylizing the RCT design to the characteristics of socially complex services.</p> </section> <section> <h3> <b>Implications:</b></h3> <p> It remains an empirical issue whether RCT-based services effectiveness research can inform mental health policy. Without major design innovations, it is more likely that the information generated by this research will have limited practical use, especially if the RCT model is unable to control for the effect of socia
背景:在循证医学的引领下,基于有效性研究的实践已成为当代公共政策的新金标准。越来越多的人要求进行此类研究,以评估心理健康、社会服务和刑事司法系统提供的服务。目的:本文质疑临床试验中应用的简单随机对照试验(RCT)范式是否可以“现成”用于评估社会复杂服务(SCS)干预措施。这些服务的特点是人员配置安排复杂、多样和不标准;模糊协议;难以定义的研究样本、动机不均衡的受试者以及对更广泛社会环境的依赖。探讨了在现实世界条件下确保精确的方案、等效群体(与有意义的目标人群挂钩)以及中立和等效的试验环境的困难,以及未实现标准化和等效的影响。方法:通过将支持简单随机对照试验的假设与SCS干预的特征进行比较,检验有效性研究作为研究工具和信息来源的局限性,如英国针对精神障碍罪犯的项目所示。结果:SCS违反了简单随机对照试验模型的假设,使SCS试验推断的有效性、可靠性和可推广性受到尖锐质疑。讨论:随机对照试验不是万灵药。基于随机对照试验模型的SCS干预措施的有效性研究不太可能产生有效、可靠和可推广的推论,而不会在设计上变得更加复杂,对选择偏差、未测量变量和内生性问题更加敏感。针对社会复杂服务的特点,提出了十条关于RCT设计风格化的建议。影响:基于随机对照试验的服务有效性研究是否能为心理健康政策提供信息仍然是一个实证问题。如果没有重大的设计创新,这项研究产生的信息更有可能具有有限的实际用途,特别是如果RCT模型无法控制社会复杂性的影响以及社会复杂性与动态系统变化之间的互动。对服务的科学评估具有临床和经济意义,只要它们旨在应对服务的挑战,并承诺提供更多的知识。版权所有©2000 John Wiley&;有限公司。
{"title":"Using randomized controlled trials to evaluate socially complex services: problems, challenges and recommendations","authors":"Nancy Wolff","doi":"10.1002/1099-176X(200006)3:2<97::AID-MHP77>3.0.CO;2-S","DOIUrl":"https://doi.org/10.1002/1099-176X(200006)3:2<97::AID-MHP77>3.0.CO;2-S","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; &lt;b&gt;Background:&lt;/b&gt;&lt;/h3&gt;\u0000 \u0000 &lt;p&gt; Following the lead of evidence-based medicine, practice based on effectiveness research has become the new gold standard of contemporary public policy. Studies of this sort are increasingly demanded to evaluate services provided by mental health, social services and criminal justice systems.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; &lt;b&gt;Aims:&lt;/b&gt;&lt;/h3&gt;\u0000 \u0000 &lt;p&gt; The paper questions whether the simple randomized controlled trial (RCT) paradigm as applied in clinical trials can be used ‘off the rack’ to evaluate &lt;i&gt;socially complex service (SCS) interventions&lt;/i&gt;. These are services that are characterized by complex, diverse and non-standardized staffing arrangements; ambiguous protocols; hard-to-define study samples and unevenly motivated subjects and dependence on broader social environments. The difficulty of ensuring precise protocols, equivalent groups (tied to a meaningful target population) and neutral and equivalent trial environments under real world conditions are explored, as are the implications of not achieving standardization and equivalence.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; &lt;b&gt;Methods:&lt;/b&gt;&lt;/h3&gt;\u0000 \u0000 &lt;p&gt; Limitations of effectiveness research as a research tool and information source are examined by comparing the assumptions underpinning the simple RCT to the characteristics of SCS interventions, as illustrated by programs targeted to mentally disordered offenders in Britain.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; &lt;b&gt;Results:&lt;/b&gt;&lt;/h3&gt;\u0000 \u0000 &lt;p&gt; SCSs violate the assumptions underpinning the simple RCT model in ways that draw into sharp question the validity, reliability and generalizability of inferences of SCS trials.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; &lt;b&gt;Discussion:&lt;/b&gt;&lt;/h3&gt;\u0000 \u0000 &lt;p&gt; The RCT is not a panacea. Effectiveness research of SCS interventions that is based on the RCT model is unlikely to yield valid, reliable and generalizable inferences without becoming more complex in design and more sensitive to issues of selection bias, unmeasured variables and endogeneity. Ten recommendations are offered for stylizing the RCT design to the characteristics of socially complex services.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; &lt;b&gt;Implications:&lt;/b&gt;&lt;/h3&gt;\u0000 \u0000 &lt;p&gt; It remains an empirical issue whether RCT-based services effectiveness research can inform mental health policy. Without major design innovations, it is more likely that the information generated by this research will have limited practical use, especially if the RCT model is unable to control for the effect of socia","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"3 2","pages":"97-109"},"PeriodicalIF":1.6,"publicationDate":"2000-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/1099-176X(200006)3:2<97::AID-MHP77>3.0.CO;2-S","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72162503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 103
Abstracts translations 摘要翻译
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2000-11-23 DOI: 10.1002/1099-176X(200006)3:2<115::AID-MHP84>3.0.CO;2-H

To view the abstracts translations in Russian please go to the full text PDF file.

要查看俄语摘要翻译,请访问全文PDF文件。
{"title":"Abstracts translations","authors":"","doi":"10.1002/1099-176X(200006)3:2<115::AID-MHP84>3.0.CO;2-H","DOIUrl":"https://doi.org/10.1002/1099-176X(200006)3:2<115::AID-MHP84>3.0.CO;2-H","url":null,"abstract":"<p>To view the abstracts translations in Russian please go to the full text PDF file.</p>","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"3 2","pages":"115-117"},"PeriodicalIF":1.6,"publicationDate":"2000-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/1099-176X(200006)3:2<115::AID-MHP84>3.0.CO;2-H","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72162500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addiction:entries and exits. Edited by Jon Elster. New York: Sage, 1999 上瘾:进入和退出。乔恩·埃尔斯特编辑。纽约:Sage, 1999
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2000-09-01 DOI: 10.1002/MHP.92
R. Pacula
{"title":"Addiction:entries and exits. Edited by Jon Elster. New York: Sage, 1999","authors":"R. Pacula","doi":"10.1002/MHP.92","DOIUrl":"https://doi.org/10.1002/MHP.92","url":null,"abstract":"","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"21 1","pages":"165-166"},"PeriodicalIF":1.6,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78740860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
How can policy makers use available evidence on the cost benefits of drug treatement? 政策制定者如何利用现有证据证明药物治疗的成本效益?
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2000-07-19 DOI: 10.1002/1099-176X(200003)3:1<55::AID-MHP70>3.0.CO;2-1
Christine Godfrey, Steve Parrott

All the studies on the cost benefits of drug treatment reviewed by Cartwright in this issue suggest benefits outweigh costs by some margin. What lessons does this review of mainly American data have for European policy makers? Drug treatments are associated with a wide range of consequences outside the health sector and there are considerable differences in treatment regimes across countries. This could well influence results. There are also considerable differences in methodologies used across available studies and many lack strong study designs. An interesting feature is the lack of valuation of individual drug users benefits, does this imply that policy makers in the US do not care about drug misusers. Would the situation be the same in Europe or other parts of the world? There is a lot of research to be done and perhaps specific guidelines are required to ensure economic evaluations in this area can be used to guide policy decisions with more confidence. Copyright ©2000 John Wiley & Sons, Ltd.

Cartwright在本期中回顾的所有关于药物治疗成本效益的研究都表明,收益在一定程度上超过了成本。这次主要针对美国数据的审查对欧洲政策制定者有什么启示?药物治疗与卫生部门以外的广泛后果有关,各国的治疗制度存在相当大的差异。这很可能会影响结果。现有研究中使用的方法也存在相当大的差异,许多研究缺乏强有力的研究设计。一个有趣的特点是缺乏对吸毒者个人利益的评估,这是否意味着美国的政策制定者不关心吸毒者。欧洲或世界其他地区的情况会是一样的吗?还有很多研究要做,也许需要具体的指导方针来确保这一领域的经济评估能够更有信心地用于指导政策决策。版权所有©2000 John Wiley&;有限公司。
{"title":"How can policy makers use available evidence on the cost benefits of drug treatement?","authors":"Christine Godfrey,&nbsp;Steve Parrott","doi":"10.1002/1099-176X(200003)3:1<55::AID-MHP70>3.0.CO;2-1","DOIUrl":"https://doi.org/10.1002/1099-176X(200003)3:1<55::AID-MHP70>3.0.CO;2-1","url":null,"abstract":"<p>All the studies on the cost benefits of drug treatment reviewed by Cartwright in this issue suggest benefits outweigh costs by some margin. What lessons does this review of mainly American data have for European policy makers? Drug treatments are associated with a wide range of consequences outside the health sector and there are considerable differences in treatment regimes across countries. This could well influence results. There are also considerable differences in methodologies used across available studies and many lack strong study designs. An interesting feature is the lack of valuation of individual drug users benefits, does this imply that policy makers in the US do not care about drug misusers. Would the situation be the same in Europe or other parts of the world? There is a lot of research to be done and perhaps specific guidelines are required to ensure economic evaluations in this area can be used to guide policy decisions with more confidence. Copyright ©2000 John Wiley &amp; Sons, Ltd.</p>","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"3 1","pages":"55"},"PeriodicalIF":1.6,"publicationDate":"2000-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/1099-176X(200003)3:1<55::AID-MHP70>3.0.CO;2-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72157706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Cost–benefit analysis of drug treatment services: review of the literature† 药物治疗服务的成本效益分析:文献综述†
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2000-07-19 DOI: 10.1002/1099-176X(200003)3:1<11::AID-MHP66>3.0.CO;2-0
William S. Cartwright
<div> <section> <h3> Background:</h3> <p>How valuable is public investment in treatment for drug abuse and dependency in the real world of everyday practice? Does drug abuse treatment provide benefits and how are they valued? What are the costs of obtaining outcomes and benefits? Cost–benefit analysis attempts to answer these questions in a standard analytic framework.</p> </section> <section> <h3> Aims:</h3> <p>This paper reviews cost–benefit analyses with scientific merit so that analysts will have a current picture of the state of the research. It will also give public decision-makers information with regards to the available evidence for policy purposes.</p> </section> <section> <h3> Method:</h3> <p>Bibliographic searches were performed. Studies were obtained through the assistance of the Parklawn Health Library system, a component of the US Public Health Service. Selected studies were from the scientific literature with the exception of eight studies published as governmental reports.</p> </section> <section> <h3> Results:</h3> <p>Cost–benefit studies have fallen into the following categories: (i) planning models for delivery systems in states and cities; (ii) short-term follow-up studies of individuals, (iii) single individual programs and (iv) state system's monitoring of outcomes. In 18 cost–benefit studies, a persistent finding is that benefits exceed costs, even when not all benefits are accounted for in the analysis. Much variation is found in the implementation of cost–benefit methods, and this is detailed across discussions of effectiveness, benefits and costs. Studies have emphasized the cost savings to society from the reduction in external costs created by the behavioral consequences of addiction and drug use.</p> </section> <section> <h3> Discussion:</h3> <p>Economic analysis of drug treatment requires sophisticated conceptualization and measurement. Cost–benefit analysis of drug treatment has been a significant analytical exercise since the early 1970s when the public drug treatment system was founded in the United States.</p> </section> <section> <h3> Conclusion:</h3> <p>Drug abuse treatment services may be considered as contributing positive economic returns to society. However, considerable work needs to be done to standardize methods used in the studies. A striking area of omission is the absence of studies for adolescents and only one for women in treatment.</p> </section> <section> <
背景:在日常实践的现实世界中,对药物滥用和依赖性治疗的公共投资有多大价值?药物滥用治疗是否能带来好处?如何评价这些好处?获得成果和收益的成本是多少?成本效益分析试图在标准分析框架中回答这些问题。目的:本文回顾了具有科学价值的成本效益分析,以便分析师了解研究现状。它还将向公共决策者提供有关政策目的可用证据的信息。方法:进行文献检索。研究是在美国公共卫生服务局下属的帕克劳恩健康图书馆系统的协助下进行的。选定的研究来自科学文献,但作为政府报告发表的八项研究除外。结果:成本效益研究分为以下几类:(i)各州和城市配送系统的规划模型;(ii)个体的短期随访研究,(iii)单个个体项目和(iv)国家系统对结果的监测。在18项成本效益研究中,一个持续的发现是效益超过成本,即使分析中没有考虑到所有效益。在成本效益方法的实施过程中发现了许多差异,这在有效性、效益和成本的讨论中得到了详细说明。研究强调,通过减少成瘾和吸毒的行为后果所产生的外部成本,可以为社会节省成本。讨论:药物治疗的经济分析需要复杂的概念化和衡量。自20世纪70年代初美国建立公共药物治疗系统以来,药物治疗的成本效益分析一直是一项重要的分析工作。结论:药物滥用治疗服务可被视为对社会有积极的经济回报。然而,要使研究中使用的方法标准化,还需要做大量的工作。一个引人注目的遗漏领域是缺乏针对青少年的研究,只有一项针对接受治疗的妇女的研究。对医疗保健提供和使用的影响:找到一个正的净社会福利应该有助于决策者做出与药物滥用治疗支出有关的决定。还需要为各种药物治疗服务分配预算资金。对卫生政策制定的影响:政府机构和国家卫生保健系统的其他利益相关者必须认识到,成本效益研究是决策的重要工具。合理的战略只能通过研究有效分配和公平分配稀缺资源的替代方案来解决。对进一步研究的启示:未来的研究应侧重于标准化成本效益分析中使用的方法。延期应审查与支付意愿方法相关的方法。需要对针对青少年和妇女的药物滥用治疗进行研究。应该在科学文献中发表更多的研究。2000年由John Wiley&;有限公司。
{"title":"Cost–benefit analysis of drug treatment services: review of the literature†","authors":"William S. Cartwright","doi":"10.1002/1099-176X(200003)3:1<11::AID-MHP66>3.0.CO;2-0","DOIUrl":"https://doi.org/10.1002/1099-176X(200003)3:1<11::AID-MHP66>3.0.CO;2-0","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;How valuable is public investment in treatment for drug abuse and dependency in the real world of everyday practice? Does drug abuse treatment provide benefits and how are they valued? What are the costs of obtaining outcomes and benefits? Cost–benefit analysis attempts to answer these questions in a standard analytic framework.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Aims:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This paper reviews cost–benefit analyses with scientific merit so that analysts will have a current picture of the state of the research. It will also give public decision-makers information with regards to the available evidence for policy purposes.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Method:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Bibliographic searches were performed. Studies were obtained through the assistance of the Parklawn Health Library system, a component of the US Public Health Service. Selected studies were from the scientific literature with the exception of eight studies published as governmental reports.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Cost–benefit studies have fallen into the following categories: (i) planning models for delivery systems in states and cities; (ii) short-term follow-up studies of individuals, (iii) single individual programs and (iv) state system's monitoring of outcomes. In 18 cost–benefit studies, a persistent finding is that benefits exceed costs, even when not all benefits are accounted for in the analysis. Much variation is found in the implementation of cost–benefit methods, and this is detailed across discussions of effectiveness, benefits and costs. Studies have emphasized the cost savings to society from the reduction in external costs created by the behavioral consequences of addiction and drug use.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Discussion:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Economic analysis of drug treatment requires sophisticated conceptualization and measurement. Cost–benefit analysis of drug treatment has been a significant analytical exercise since the early 1970s when the public drug treatment system was founded in the United States.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusion:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Drug abuse treatment services may be considered as contributing positive economic returns to society. However, considerable work needs to be done to standardize methods used in the studies. A striking area of omission is the absence of studies for adolescents and only one for women in treatment.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"3 1","pages":"11-26"},"PeriodicalIF":1.6,"publicationDate":"2000-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/1099-176X(200003)3:1<11::AID-MHP66>3.0.CO;2-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72157708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 149
Depression: cost-of-illness studies in the international literature, a review 抑郁症:国际文献中的疾病成本研究综述
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2000-07-19 DOI: 10.1002/1099-176X(200003)3:1<3::AID-MHP68>3.0.CO;2-H
Patrizia Berto, Daniele D'Ilario, Pierfrancesco Ruffo, Roberto Di Virgilio, Fortunato Rizzo
BACKGROUND: Depression is one of the most ancient and common diseases of the human race and its burden on society is really impressive. This stems both from the epidemiological spread (lifetime prevalence rate, up to 30 years of age, was estimated as greater than 14.4% by Angst et al.) and from the economic burden on healthcare systems and society, but also as it pertains to patient well-being. AIMS OF THE STUDY: The scope of this review was to examine studies published in the international literature to describe and compare the social costs of depression in various countries. METHODS: A bibliographic search was performed on international medical literature databases (Medline, Embase), where all studies published after 1970 were selected. Studies were carefully evaluated and only those that provided cost data were included in the comparative analysis; this latter phase was conducted using a newly developed evaluation chart. RESULTS: 10 abstracts were firstly selected; 46 of them underwent a subsequent full paper reading, thus providing seven papers, which were the subject of the in-depth comparative analysis: three studies investigated the cost of depression in the USA, three studies in the UK and one study was related to Italy. All the studies examined highlight the relevant economic burden of depression; in 1990, including both direct and indirect costs, it accounted for US$ 43.7 billion in the US (US$ 65 billion, at 1998 prices) according to Greenberg and colleagues, whilst direct costs accounted for £417 million in the UK (or US$ 962.5 million, at 1998 prices), according to Kind and Sorensen. Within direct costs, the major cost driver was indeed hospitalization, which represented something in between 43 and 75% of the average per patient cost; conversely, drug cost accounted for only 2% to 11% in five out of seven studies. DISCUSSION: Indeed, our review suggests that at the direct cost level, in both the United States and the United Kingdom, the burden of depression is remarkable, and this is confirmed by a recent report issued by the Pharmaceutical Research and Manufacturers Association (PhRMA) where prevalence and cost of disease were compared for several major chronic diseases, including Alzheimer, asthma, cancer, depression, osteoporosis, hypertension, schizophrenia and others: in this comparison, depression is one of the most significant diseases, ranked third by prevalence and sixth in terms of economic burden. Moreover, in terms of the average cost per patient, depression imposes a societal burden that is larger than other chronic conditions such as hypertension, rheumatoid arthritis, asthma and osteoporosis. The application of economic methods to the epidemiological and clinical field is a relatively recent development, as evidenced by the finding that, out of the seven studies examined, three refer to the US environment, three to the UK and one to Italy, while nothing was available about the cost of depression for large countries suc
{"title":"Depression: cost-of-illness studies in the international literature, a review","authors":"Patrizia Berto,&nbsp;Daniele D'Ilario,&nbsp;Pierfrancesco Ruffo,&nbsp;Roberto Di Virgilio,&nbsp;Fortunato Rizzo","doi":"10.1002/1099-176X(200003)3:1<3::AID-MHP68>3.0.CO;2-H","DOIUrl":"https://doi.org/10.1002/1099-176X(200003)3:1<3::AID-MHP68>3.0.CO;2-H","url":null,"abstract":"BACKGROUND: Depression is one of the most ancient and common diseases of the human race and its burden on society is really impressive. This stems both from the epidemiological spread (lifetime prevalence rate, up to 30 years of age, was estimated as greater than 14.4% by Angst et al.) and from the economic burden on healthcare systems and society, but also as it pertains to patient well-being. AIMS OF THE STUDY: The scope of this review was to examine studies published in the international literature to describe and compare the social costs of depression in various countries. METHODS: A bibliographic search was performed on international medical literature databases (Medline, Embase), where all studies published after 1970 were selected. Studies were carefully evaluated and only those that provided cost data were included in the comparative analysis; this latter phase was conducted using a newly developed evaluation chart. RESULTS: 10 abstracts were firstly selected; 46 of them underwent a subsequent full paper reading, thus providing seven papers, which were the subject of the in-depth comparative analysis: three studies investigated the cost of depression in the USA, three studies in the UK and one study was related to Italy. All the studies examined highlight the relevant economic burden of depression; in 1990, including both direct and indirect costs, it accounted for US$ 43.7 billion in the US (US$ 65 billion, at 1998 prices) according to Greenberg and colleagues, whilst direct costs accounted for £417 million in the UK (or US$ 962.5 million, at 1998 prices), according to Kind and Sorensen. Within direct costs, the major cost driver was indeed hospitalization, which represented something in between 43 and 75% of the average per patient cost; conversely, drug cost accounted for only 2% to 11% in five out of seven studies. DISCUSSION: Indeed, our review suggests that at the direct cost level, in both the United States and the United Kingdom, the burden of depression is remarkable, and this is confirmed by a recent report issued by the Pharmaceutical Research and Manufacturers Association (PhRMA) where prevalence and cost of disease were compared for several major chronic diseases, including Alzheimer, asthma, cancer, depression, osteoporosis, hypertension, schizophrenia and others: in this comparison, depression is one of the most significant diseases, ranked third by prevalence and sixth in terms of economic burden. Moreover, in terms of the average cost per patient, depression imposes a societal burden that is larger than other chronic conditions such as hypertension, rheumatoid arthritis, asthma and osteoporosis. The application of economic methods to the epidemiological and clinical field is a relatively recent development, as evidenced by the finding that, out of the seven studies examined, three refer to the US environment, three to the UK and one to Italy, while nothing was available about the cost of depression for large countries suc","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"3 1","pages":"3-10"},"PeriodicalIF":1.6,"publicationDate":"2000-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/1099-176X(200003)3:1<3::AID-MHP68>3.0.CO;2-H","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72190168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 219
Capitated payments for mental health patients: a comparison of potential approaches in a public sector population 精神健康患者的资本化支付:公共部门人群中潜在方法的比较
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2000-07-19 DOI: 10.1002/1099-176X(200003)3:1<35::AID-MHP69>3.0.CO;2-I
Douglas L. Leslie, Robert Rosenheck, William D. White
<div> <section> <h3> Background:</h3> <p>Both private and public health care systems have embraced capitated reimbursement as a method of controlling costs.</p> </section> <section> <h3> Aims of the Study:</h3> <p>This study explores the financial implications of using reimbursement models based on clinically based patient classification schemes to distribute funds for the treatment of mental health patients in the Department of Veterans Affairs (VA).</p> </section> <section> <h3> Methods:</h3> <p>We identified 53700 veterans treated in VA specialty mental health outpatient clinics during the first 2 weeks of fiscal year (FY) 1991 for whom relevant clinical data were available. We calculated total utilization and costs for this sample during the remainder of FY 1991 using VA administrative databases and simulated hypothetical distributions of funds based on seven alternative capitation models. The resulting distributions of funds across service networks and facility types were compared to actual expenditures.</p> </section> <section> <h3> Results:</h3> <p>Approximately 8% of overall VA budget was redistributed under a simple capitated scheme, and some individual networks and facility types experienced changes in funding of over 30%. Models based on clinical data resulted in only minor differences from average-cost reimbursement. Substantial variation in practice style was observed across Veterans Integrated Service Networks (VISNs), which was significantly associated with funding shifts under capitation.</p> </section> <section> <h3> Discussion:</h3> <p>A simple capitated payment scheme would result in large changes in funding for some VISNs. Adjustments for case mix did not substantially affect patterns of redistribution. Patterns of redistribution appear to reflect large differences in practice style across VISNs. Although a capitated system will create incentives to reduce such variation, the effect of such shifts on patient well-being is unknown.</p> </section> <section> <h3> Implications for Health Policies:</h3> <p>Any capitated system will create incentives to provide a uniform standard of care. In our analyses, the capitation rate was based on the average cost per treated patient in each category; however rates could be set higher or lower as policy makers deem necessary. The standard of care associated with the average cost is not necessarily the ‘correct’ level of care.</p> </section> <section> <h
背景:私人和公共医疗保健系统都将按人头付费作为控制成本的一种方法。研究目的:本研究探讨了在退伍军人事务部(VA)使用基于临床的患者分类方案的报销模式来分配精神健康患者治疗资金的财务影响。方法:我们确定了1991财政年度(FY)前两周在退伍军人事务部专业心理健康门诊接受治疗的53700名退伍军人,他们的相关临床数据可用。我们使用VA管理数据库计算了该样本在1991财年剩余时间的总利用率和成本,并基于七种替代的按人头计算模型模拟了假设的资金分配。将由此产生的跨服务网络和设施类型的资金分配与实际支出进行了比较。结果:大约8%的退伍军人事务总预算是根据简单的按人头分配计划重新分配的,一些个别网络和设施类型的资金变化超过30%。基于临床数据的模型与平均费用报销仅产生微小差异。在退伍军人综合服务网络(VISN)中观察到实践风格的巨大差异,这与按人头计算的资金转移显著相关。讨论:一个简单的按人头付费计划将导致一些VISN的资金发生巨大变化。对病例组合的调整并没有对再分配模式产生实质性影响。再分配模式似乎反映了VISN之间实践风格的巨大差异。尽管按人头计算的制度会产生减少这种变化的激励措施,但这种变化对患者健康的影响尚不清楚。对卫生政策的影响:任何按人头计算的制度都将产生激励措施,以提供统一的护理标准。在我们的分析中,按人头付费率是基于每个类别中每个接受治疗的患者的平均费用;然而,政策制定者认为必要时,利率可以设定得更高或更低。与平均费用相关的护理标准不一定是“正确”的护理水平。对进一步研究的启示:我们的分析探讨了在没有行为改变的情况下,人头系统对心理健康患者的启示。需要进一步的研究来确定提供者实际上是如何应对按人头付费产生的不同激励措施的,以及这些变化对患者健康的影响。版权所有©2000 John Wiley&;有限公司。
{"title":"Capitated payments for mental health patients: a comparison of potential approaches in a public sector population","authors":"Douglas L. Leslie,&nbsp;Robert Rosenheck,&nbsp;William D. White","doi":"10.1002/1099-176X(200003)3:1<35::AID-MHP69>3.0.CO;2-I","DOIUrl":"https://doi.org/10.1002/1099-176X(200003)3:1<35::AID-MHP69>3.0.CO;2-I","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Both private and public health care systems have embraced capitated reimbursement as a method of controlling costs.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Aims of the Study:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This study explores the financial implications of using reimbursement models based on clinically based patient classification schemes to distribute funds for the treatment of mental health patients in the Department of Veterans Affairs (VA).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;We identified 53700 veterans treated in VA specialty mental health outpatient clinics during the first 2 weeks of fiscal year (FY) 1991 for whom relevant clinical data were available. We calculated total utilization and costs for this sample during the remainder of FY 1991 using VA administrative databases and simulated hypothetical distributions of funds based on seven alternative capitation models. The resulting distributions of funds across service networks and facility types were compared to actual expenditures.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Approximately 8% of overall VA budget was redistributed under a simple capitated scheme, and some individual networks and facility types experienced changes in funding of over 30%. Models based on clinical data resulted in only minor differences from average-cost reimbursement. Substantial variation in practice style was observed across Veterans Integrated Service Networks (VISNs), which was significantly associated with funding shifts under capitation.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Discussion:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A simple capitated payment scheme would result in large changes in funding for some VISNs. Adjustments for case mix did not substantially affect patterns of redistribution. Patterns of redistribution appear to reflect large differences in practice style across VISNs. Although a capitated system will create incentives to reduce such variation, the effect of such shifts on patient well-being is unknown.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Implications for Health Policies:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Any capitated system will create incentives to provide a uniform standard of care. In our analyses, the capitation rate was based on the average cost per treated patient in each category; however rates could be set higher or lower as policy makers deem necessary. The standard of care associated with the average cost is not necessarily the ‘correct’ level of care.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"3 1","pages":"35-44"},"PeriodicalIF":1.6,"publicationDate":"2000-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/1099-176X(200003)3:1<35::AID-MHP69>3.0.CO;2-I","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72157721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Abstracts translations 摘要翻译
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2000-07-19 DOI: 10.1002/1099-176X(200003)3:1<56::AID-MHP82>3.0.CO;2-U
Ella Rytik

Please see the PDF file for the abstracts translations in Russian.

请参阅PDF文件中的摘要俄语翻译。
{"title":"Abstracts translations","authors":"Ella Rytik","doi":"10.1002/1099-176X(200003)3:1<56::AID-MHP82>3.0.CO;2-U","DOIUrl":"https://doi.org/10.1002/1099-176X(200003)3:1<56::AID-MHP82>3.0.CO;2-U","url":null,"abstract":"<p>Please see the PDF file for the abstracts translations in Russian.</p>","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"3 1","pages":"56-58"},"PeriodicalIF":1.6,"publicationDate":"2000-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/1099-176X(200003)3:1<56::AID-MHP82>3.0.CO;2-U","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72157707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resource distribution in mental health services: changes in geographic location and use of personnel in Norwegian mental health services 1979–1994 心理健康服务的资源分布:1979年至1994年挪威心理健康服务地理位置和人员使用的变化
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2000-07-19 DOI: 10.1002/1099-176X(200003)3:1<45::AID-MHP71>3.0.CO;2-1
Per Bernhard Pedersen, Solfrid Lilleeng
<div> <section> <h3> Background:</h3> <p>During the last decades, a central aim of Norwegian health policy has been to achieve a more equal geographical distribution of services. Of special interest is the 1980 financial reform. Central government reimbursements for the treatment of in-patients were replaced by a block grant to each county, based on indicators of relative ‘need’.</p> </section> <section> <h3> Aims of the study:</h3> <p>The aim of this paper is to assess whether the distribution of specialized mental health services did take the course suggested by the proponents of the reform (i.e. a more equal distribution), or the opposite (i.e. a more unequal distribution) as claimed by the opponents.</p> </section> <section> <h3> Methods:</h3> <p>Man year <i>per capita</i> ratios were used as indicators for the distribution of mental health services by county. Ratios were estimated for ‘all personnel’, and for MDs and psychologists separately. Man years were assigned to counties by <i>location</i> of services (i.e. in which county the services were produced), and by <i>residence</i> of users (i.e. in which county the services were consumed). Indicators of geographic variation were estimated using the standard deviation (STD) as a measure of <i>absolute variation</i>, and the coefficient of variation (CV) and the Gini index as indicators of <i>relative variation</i>. Indicators were estimated for 1979, 1984, 1989 and 1994, based on data for all specialized adult mental health services in the country. Changes in distributions over the period were tested, using Levene's test of homogeneity.</p> </section> <section> <h3> Results:</h3> <p>Relative variations in the distribution of personnel by <i>location of services</i> were substantially reduced over the period, the CV being reduced by more than 50% for all groups. Variations in the personnel ratios by <i>residence of users</i> were smaller at the start of the period, and the reductions were also smaller. Still, relative variations were reduced by 20–35, 40 and 60% approximately for ‘all personnel’, MDs and psychologists respectively. In spite of a major increase in the supply of MDs and psychologists, <i>absolute</i> variations in the personnel ratios were in all cases either reduced, or fairly stable.</p> <p>These results give little support to the views expressed by the opponents of the 1980 reform, although the main result seems to have been relocations in the <i>production of services</i>, more than re-distributions in the <i>consumption of services</i>.</p> </section> <section> <h3> D
背景:在过去几十年中,挪威卫生政策的中心目标是实现服务的更平等的地域分配。特别令人感兴趣的是1980年的金融改革。中央政府对住院患者治疗的报销被根据相对“需求”指标向每个县提供的整笔补助所取代。研究目的:本文的目的是评估专业心理健康服务的分配是否遵循了改革支持者建议的路线(即更平等的分配),还是与反对者所声称的相反(即更不平等的分布)。方法:采用人年人均比率作为分县心理健康服务分布的指标。对“所有人员”、医学博士和心理学家的比率分别进行了估计。人年按服务地点(即服务在哪个县生产)和用户居住地(即服务消费在哪个县)分配给各县。使用标准差(STD)作为绝对变异的衡量标准,使用变异系数(CV)和基尼指数作为相对变异的指标来估计地理变异指标。根据该国所有专业成人心理健康服务的数据,估计了1979年、1984年、1989年和1994年的指标。使用Levene的均匀性测试来测试这段时间内分布的变化。结果:在此期间,按服务地点划分的人员分布的相对差异显著减少,所有群体的CV都减少了50%以上。本期初,按用户居住地划分的人员比例变化较小,减少的幅度也较小。尽管如此,“所有人员”、医学博士和心理学家的相对差异分别减少了20-35%、40%和60%。尽管医学博士和心理学家的供应大幅增加,但在所有情况下,人员比例的绝对变化要么减少,要么相当稳定。这些结果几乎没有支持1980年改革反对者所表达的观点,尽管主要结果似乎是服务生产的转移,而不是服务消费的再分配。讨论:这些结果可以看作是改革三个方面的结果:1以服务使用者而非服务生产者的身份向各县发放政府补助金。这种转变主要促进了服务生产的搬迁。2由于距离的缩短将增加可及性,预计服务的搬迁也将使服务的使用分配更加平等。然而,通过使用其他县的服务来加强县控制,抵消了这一点。3根据“需求”而非所提供的服务分配赠款,预计将在服务使用方面产生更平等的分配。这种影响似乎比预期的要小,可能是因为在旧制度下报销金额高的县也为其他县的人提供服务。然而,其他政策改革也促成了这一结果。这些改革包括增加人员供应、服务机构化、服务区域化/部门化,以及在综合医院建立较小的精神科。政策影响:近年来,1980年的改革受到攻击;部分原因是所谓的制度造成的不平等。由于这一批评,政府对普通医院服务的住院治疗费用重新进行了报销。在心理健康服务方面,将更多的资源分配给特定的项目。根据这项研究,这种政策转变是基于错误的前提,并可能在未来导致更大的不平等。版权所有©2000 John Wiley&;有限公司。
{"title":"Resource distribution in mental health services: changes in geographic location and use of personnel in Norwegian mental health services 1979–1994","authors":"Per Bernhard Pedersen,&nbsp;Solfrid Lilleeng","doi":"10.1002/1099-176X(200003)3:1<45::AID-MHP71>3.0.CO;2-1","DOIUrl":"https://doi.org/10.1002/1099-176X(200003)3:1<45::AID-MHP71>3.0.CO;2-1","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;During the last decades, a central aim of Norwegian health policy has been to achieve a more equal geographical distribution of services. Of special interest is the 1980 financial reform. Central government reimbursements for the treatment of in-patients were replaced by a block grant to each county, based on indicators of relative ‘need’.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Aims of the study:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The aim of this paper is to assess whether the distribution of specialized mental health services did take the course suggested by the proponents of the reform (i.e. a more equal distribution), or the opposite (i.e. a more unequal distribution) as claimed by the opponents.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Man year &lt;i&gt;per capita&lt;/i&gt; ratios were used as indicators for the distribution of mental health services by county. Ratios were estimated for ‘all personnel’, and for MDs and psychologists separately. Man years were assigned to counties by &lt;i&gt;location&lt;/i&gt; of services (i.e. in which county the services were produced), and by &lt;i&gt;residence&lt;/i&gt; of users (i.e. in which county the services were consumed). Indicators of geographic variation were estimated using the standard deviation (STD) as a measure of &lt;i&gt;absolute variation&lt;/i&gt;, and the coefficient of variation (CV) and the Gini index as indicators of &lt;i&gt;relative variation&lt;/i&gt;. Indicators were estimated for 1979, 1984, 1989 and 1994, based on data for all specialized adult mental health services in the country. Changes in distributions over the period were tested, using Levene's test of homogeneity.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results:&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Relative variations in the distribution of personnel by &lt;i&gt;location of services&lt;/i&gt; were substantially reduced over the period, the CV being reduced by more than 50% for all groups. Variations in the personnel ratios by &lt;i&gt;residence of users&lt;/i&gt; were smaller at the start of the period, and the reductions were also smaller. Still, relative variations were reduced by 20–35, 40 and 60% approximately for ‘all personnel’, MDs and psychologists respectively. In spite of a major increase in the supply of MDs and psychologists, &lt;i&gt;absolute&lt;/i&gt; variations in the personnel ratios were in all cases either reduced, or fairly stable.&lt;/p&gt;\u0000 \u0000 &lt;p&gt;These results give little support to the views expressed by the opponents of the 1980 reform, although the main result seems to have been relocations in the &lt;i&gt;production of services&lt;/i&gt;, more than re-distributions in the &lt;i&gt;consumption of services&lt;/i&gt;.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; D","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"3 1","pages":"45-53"},"PeriodicalIF":1.6,"publicationDate":"2000-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/1099-176X(200003)3:1<45::AID-MHP71>3.0.CO;2-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72190170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
Journal of Mental Health Policy and Economics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1